Hardman & Co’s Tony Williams discusses the market’s reaction to Brexit, whether this is a re-run of the global financial crisis and the effect of Brexit on house prices and the housing market in this exclusive interview with DirectorsTalk
The pilot episode of the much-hyped new TV series ‘Billions’ raked up almost three million viewers on debut in January of this year, which was a new record for Showtime.
Hardman & Co.’s Doug Hawkins discusses the $300 billion cocoa brand value, the upstream sector, pressures for change, opportunities for ordinary investors and Hardman & Co.’s role in the cocoa sector in this exclusive interview with DirectorsTalk
Lombard Risk Management Plc (LON:LRM) has raised £8m+ (gross) to invest in products for growth. The emphasis is on cementing LRM’s position in the huge fintech market of banking risk
Hardman & Co’s Antony Gifford discusses his recent article ‘The Capital Cycle of a Growth Company’ in this exclusive interview with DirectorsTalk
Verona Pharma Plc (LON:VRP) is developing first-in-class drugs to treat unmet medical needs in respiratory disease. Over the last two years’ VRP has reported positive outcomes from a five stage
TNG Limited (ASX:TNG) progress towards production continues with two out of three product offtakes now in place, a binding agreement for the refinery design, potential for international processing plant sales
Lombard Risk Management Plc (LON:LRM) reported results on 26 May: as anticipated, a loss. LRM is all about the sustainable delivery of sales growth from investments in software, marketing and
Titon Holdings plc (LON:TON) is the subject of the latest report from Harman & Co: William Rees-Mogg famously copied Pope’s words in ‘The Times’ in 1967, questioning the source and
Allergy Therapeutics Plc (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. It’s lead product, Pollinex Quattro is available in Europe only on a ‘Named Patient’
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
